Form NT 10-Q CEN BIOTECH INC For: Jun 30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25

SEC FILE NUMBER

000-55557

CUSIP NUMBER

NOTIFICATION OF LATE FILING

(Check one):

[_] Form 10-K            [_] Form 20-F           [_] Form 11-K           [X] Form 10-Q           [_] Form 10-D
[_] Form N-CEN        [_] Form N-CSR

For Period Ended: June 30, 2022

[_] Transition Report on Form 10-K
[_] Transition Report on Form 20-F
[_] Transition Report on Form 11-K
[_] Transition Report on Form 10-Q
 
For the Transition Period Ended: ____________________

CEN BIOTECH, INC.

Full Name of Registrant

Former Name if Applicable

300-3295 Quality Way

Address of Principal Executive Office (Street and Number)

Windsor, Ontario, Canada N8T 3R9

City, State and Zip Code

[X]

(a)

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

(1)

Name and telephone number of person to contact in regard to this notification

Brian S. Payne

519

419-4958

(Name)

(Area Code)

(Telephone Number)

(2)

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

Yes  [X]     NO  [_]

(3)

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes  [ ]     NO  [X]

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Date:  

August 15, 2022

By: /s/

/s/ Brian S. Payne

Name:

Brian S. Payne

Title:

Chief Executive Officer